MENU
+Compare
PRCT
Stock ticker: NASDAQ
AS OF
Oct 20 closing price
Price
$34.72
Change
+$1.75 (+5.31%)
Capitalization
1.93B

PRCT PROCEPT BioRobotics Corp Forecast, Technical & Fundamental Analysis

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology... Show more

PRCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PRCT with price predictions
Oct 20, 2025

PRCT's RSI Oscillator ascending out of oversold territory

The RSI Oscillator for PRCT moved out of oversold territory on October 14, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 30 similar instances when the indicator left oversold territory. In of the 30 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 50 cases where PRCT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PRCT just turned positive on October 15, 2025. Looking at past instances where PRCT's MACD turned positive, the stock continued to rise in of 33 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PRCT advanced for three days, in of 218 cases, the price rose further within the following month. The odds of a continued upward trend are .

PRCT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PRCT as a result. In of 70 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRCT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PRCT entered a downward trend on October 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.008) is normal, around the industry mean (61.815). P/E Ratio (0.000) is within average values for comparable stocks, (37.952). PRCT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.714). PRCT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (6.826) is also within normal values, averaging (81.090).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. PRCT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
PRCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PRCT is expected to report earnings to rise 18.09% to -41 cents per share on November 04

PROCEPT BioRobotics Corp PRCT Stock Earnings Reports
Q3'25
Est.
$-0.41
Q2'25
Beat
by $0.06
Q1'25
Beat
by $0.04
Q4'24
Missed
by $0.01
Q3'24
Beat
by $0.09
The last earnings report on August 06 showed earnings per share of -34 cents, beating the estimate of -40 cents. With 1.24M shares outstanding, the current market capitalization sits at 1.93B.
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
150 Baytech Drive
Phone
+1 650 232-7200
Employees
626
Web
https://www.procept-biorobotics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
STFAX501.38N/A
N/A
State Street Equity 500 Index Adm
LCLIX42.15N/A
N/A
ClearBridge Large Cap Value 1
GCPYX21.46N/A
N/A
Gateway Equity Call Premium Y
VGOSX68.66N/A
N/A
Voya Large-Cap Growth R6
GGYPX15.83N/A
N/A
Goldman Sachs Focused Value P

PRCT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PRCT has been loosely correlated with GKOS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PRCT jumps, then GKOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRCT
1D Price
Change %
PRCT100%
+5.31%
GKOS - PRCT
41%
Loosely correlated
-8.83%
ESTA - PRCT
40%
Loosely correlated
+4.34%
CERS - PRCT
38%
Loosely correlated
+6.54%
HAE - PRCT
37%
Loosely correlated
+0.90%
TWST - PRCT
37%
Loosely correlated
+16.26%
More

Groups containing PRCT

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRCT
1D Price
Change %
PRCT100%
+5.31%
Medical/Nursing Services
industry (219 stocks)
48%
Loosely correlated
+27.15%
Health Services
industry (427 stocks)
-12%
Poorly correlated
+14.66%